Skip to main
MREO
MREO logo

MREO Market Capitalization Overview

Market Cap: $456.33M as of Jul 3, 2025

$456.33M
Past Month+$50.88M (12.55%)
As of Jul 3, 2025, MREO has a market capitalization of $456.33M. Over the past 30 days, its market cap has increased by 8.24%, while in the last 12 months, it has decreased by -15.74%.

Market capitalization represents the total value of Mereo Biopharma Group Plc - ADR as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

MREO Market Cap Formula = Stock Price * Shares Outstanding

The market cap of MREO helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

MREO Market Cap History

DateMarket CapChange
Jul 1, 2025$438.84M+8.24%
Jun 2, 2025$405.45M+0.51%
May 1, 2025$403.38M+19.82%
Apr 1, 2025$336.67M-6.22%
Mar 3, 2025$358.99M-22.41%
Feb 3, 2025$462.66M-12.57%
Jan 2, 2025$529.20M-5.79%

MREO End of Year Market Cap History

DateMarket CapChange
2025$456.33M-15.74%
2024$541.57M+82.60%
2023$296.60M+216.40%
2022$93.74M-46.08%
2021$173.85M-28.05%
2020$241.64M

FAQs About Mereo Biopharma Group Plc - ADR (MREO) Market Cap

As of Jul 3, 2025, the market capitalization of MREO is $456.33M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Mereo Biopharma Group Plc - ADR’s market capitalization has increased by 12.55%, changing from $405.45M to $456.33M as of Jul 3, 2025.

In the last 3 months, Mereo Biopharma Group Plc - ADR’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Mereo Biopharma Group Plc - ADR’s market capitalization increased from $296.60M in January to $541.57M in December, reflecting a 82.6% change.

In the past five years, MREO has had a compound annual growth rate (CAGR) of 17.52% in market capitalization. This means its market cap has grown at an average rate of 17.52% per year.

Mereo Biopharma Group Plc - ADR (MREO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.